Translatale Biosystems Private Limited

Translatale Biosystems Private Limited - research & development in Bangalore, Karnataka, India. FY 2026 financials and compliance.
CIN U73100KA2022PTC167447 Incorporated 31 October 2022 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company research and development
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
4 yrs
Est. 2022
Last financials
Mar 2025
Balance sheet date

About Translatale Biosystems Private Limited

Data last updated: 27 February 2026

Translatale Biosystems Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It specialises in scientific research, a part of the broader research and development sector. Incorporated on 31 October 2022.

Registered with ROC Bangalore under CIN U73100KA2022PTC167447.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Varadaraju Gnaneshwar Yadav and Saurabh Kishor Mahajan.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: No 65 80Ft Road Sbm Colony Nagendra Block Banashankari 1St Stage, Bangalore, Karnataka, India – 560050.

The company is associated with 1 brand - Translatale Biosystems.

Company Details of Translatale Biosystems Private Limited
CIN U73100KA2022PTC167447
Registration Number 167447
Incorporation Date 31 October 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    No 65 80Ft Road Sbm Colony Nagendra Block Banashankari 1St Stage, Bangalore, Karnataka, India – 560050
  • Industry
    Research & Development, Science Research
Company report
Translatale Biosystems Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Translatale Biosystems Private Limited report

Financials, compliance, directors, charges, ownership and filings for Translatale Biosystems Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Translatale Biosystems Private Limited

Translatale Biosystems Private Limited operates one associated brand: Translatale Biosystems. These brands represent Translatale Biosystems Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Solutions for targeting mRNA translation in drug discovery are provided. translatale.bio

Competitors & Alternatives of Translatale Biosystems Private Limited

Brands and companies operating in the same space as Translatale Biosystems Private Limited include Noetik, Transition Bio, Function Oncology and 6 more.

Competitor Description Location Founded
Noetik Noetik Cancer immunotherapies are discovered and developed via AI platform. San Francisco, United States, United States 2022
Transition Bio Transition Bio Technology platform for biomolecular condensate analysis is developed. Cambridge, United States, United States 2020
Function Oncology Function Oncology Cancer therapeutics are developed using a CRISPR-enabled platform. San Diego, United States, United States 2018
Meliora Therapeutics Meliora Therapeutics Machine learning-driven platform for oncology drug discovery is offered. San Francisco, United States, United States 2021
OmniSeq OmniSeq Web-based solutions for genomic testing and sequencing access are provided. Buffalo, United States, United States 2015
Systems Oncology Systems Oncology Oncology focused drug discovery using biology and cognitive computing Scottsdale, United States, United States 2015
Alixia Alixia Cancer drug discovery platform is provided for tumor mutation targeting. San Francisco, United States, United States 2018
Econic Biosciences Econic Biosciences Developer of a platform for the discovery and development of targeted therapies for cancer London, United Kingdom, United Kingdom 2022
Arontier Arontier AI-driven drug discovery is focused on cancer and rare diseases. Seoul, South Korea, South Korea 2017

Board of Directors of Translatale Biosystems Private Limited

Translatale Biosystems Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Varadaraju Gnaneshwar Yadav Director 31 Oct 2022 3 Years 9 Months Current
Saurabh Kishor Mahajan Director 31 Oct 2022 3 Years 9 Months Current

Financials of Translatale Biosystems Private Limited FY 2025 filings available

Premium access

Ten-year financial statements for Translatale Biosystems Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings Translatale Biosystems Private Limited

Translatale Biosystems Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Translatale Biosystems Private Limited

View historical data on people associated with Translatale Biosystems Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Translatale Biosystems Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Translatale Biosystems Private Limited

Premium access

GST registrations and filing compliance for Translatale Biosystems Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Translatale Biosystems Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Translatale Biosystems Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Translatale Biosystems Private Limited

Premium access

MSME payment history for Translatale Biosystems Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Translatale Biosystems Private Limited

Premium access

Corporate group structure for Translatale Biosystems Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Translatale Biosystems Private Limited

Premium access

MCA filings and documents for Translatale Biosystems Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Translatale Biosystems Private Limited

Activity
30 Sep 2025
Translatale Biosystems Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Translatale Biosystems Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Directors
31 Oct 2022
Varadaraju Gnaneshwar Yadav was appointed as a Director on 31 Oct 2022 & has been associated with this company since 3 years 9 months.
Directors
31 Oct 2022
Saurabh Kishor Mahajan was appointed as a Director on 31 Oct 2022 & has been associated with this company since 3 years 9 months.
Activity
31 Oct 2022
Translatale Biosystems Private Limited was registered on 31 Oct 2022 with Roc Bangalore & aged 3 years 9 months as per MCA records.

Frequently Asked Questions about Translatale Biosystems Private Limited

Translatale Biosystems Private Limited is an active private limited company in the research and development sector based in Bangalore, Karnataka, India. It was incorporated on 31 October 2022 (4+ years old) and is registered under CIN U73100KA2022PTC167447.

The current directors of Translatale Biosystems Private Limited are:

The primary industry of Translatale Biosystems Private Limited is research and development. The company specifically operates in science research. The company is currently active in this sector.

Yes, Translatale Biosystems Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Translatale Biosystems Private Limited can be reached at the registered office: No 65 80Ft Road Sbm Colony Nagendra Block Banashankari 1St Stage, Bangalore, Karnataka, India – 560050.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available